A person's total number of visits to multiple sclerosis clinics is not associated with a lower risk of death, a study on ...

Researchers have developed a blood test to predict MS onset by measuring EBV antibody levels, potentially allowing early ...

To clarify aspects of multiple sclerosis that might be confusing, columnist Ben Hofmeister tries to use humor, analogies, and metaphors.

Mesenchymal stem cell therapy lessens disability and brain lesions in MS patients, according to a review of published studies ...

People with MS visited doctors, were hospitalized, and used emergency care more than other people decades before their ...

Columnist Desiree Lama shares some of the difficulties she faces when she travels with MS, such as fatigue and body aches.

Vibration therapy eases fatigue and improves motor and cognitive outcomes in MS, outperforming standard physical exercise ...

Columnist Leigh Anne Nelson rethinks her MS medication, discovering a risk and navigating crucial treatment decisions with ...

GFAP, or glial fibrillary acidic protein, supports star-shaped brain cells called astrocytes that help maintain nerve cell ...

Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...

Quantum Biopharma filed an innovation passport application in the U.K. to expedite the development and review of MS therapy ...

Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...